BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 23984578)

  • 1. [Reversal of rocuronium induced neuromuscular block with sugammadex in a patient with myasthenia gravis].
    Nakamori E; Nitahara K; Sugi Y; Katori K; Matsuzaki A; Higa K
    Masui; 2013 Aug; 62(8):972-4. PubMed ID: 23984578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Case of anesthesia for thoracoscopic thymectomy in a pediatric patient with myasthenia gravis: reversal of rocuronium-induced neuromuscular blockade with sugammadex].
    Takeda A; Kawamura M; Hamaya I; Kitamura H; Muto R; Mitono H
    Masui; 2012 Aug; 61(8):855-8. PubMed ID: 22991811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of sugammadex in a patient with myasthenia gravis.
    Unterbuchner C; Fink H; Blobner M
    Anaesthesia; 2010 Mar; 65(3):302-5. PubMed ID: 20105151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rocuronium and sugammadex in patients with myasthenia gravis undergoing thymectomy.
    Sungur Ulke Z; Yavru A; Camci E; Ozkan B; Toker A; Senturk M
    Acta Anaesthesiol Scand; 2013 Jul; 57(6):745-8. PubMed ID: 23678983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effective reversal of muscle relaxation by rocuronium using sugammadex in a patient with myasthenia gravis undergoing laparoscopic cholecystectomy].
    Komasawa N; Noma H; Sugi T; Sukenaga N; Kakiuchi H
    Masui; 2011 Apr; 60(4):476-9. PubMed ID: 21520600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fade of train-of-four ratio despite administration of more than 12 mg kg(-1) sugammadex in a myasthenia gravis patient receiving rocuronium.
    Kiss G; Lacour A; d'Hollander A
    Br J Anaesth; 2013 May; 110(5):854-5. PubMed ID: 23599531
    [No Abstract]   [Full Text] [Related]  

  • 7. A new approach to anesthesia management in myasthenia gravis: reversal of neuromuscular blockade by sugammadex.
    de Boer HD; van Egmond J; Driessen JJ; Booij LH
    Rev Esp Anestesiol Reanim; 2010 Mar; 57(3):181-4. PubMed ID: 20422852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
    Flockton EA; Mastronardi P; Hunter JM; Gomar C; Mirakhur RK; Aguilera L; Giunta FG; Meistelman C; Prins ME
    Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sugammadex in patients with myasthenia gravis.
    De Boer HD; Van Egmond J; Driessen JJ; Booij LHJD
    Anaesthesia; 2010 Jun; 65(6):653. PubMed ID: 20565409
    [No Abstract]   [Full Text] [Related]  

  • 10. [Sugammadex reversal of neuromuscular blockade for thymectomy in a patient with myasthenia gravis].
    Monsalve Naharro JA; Gerónimo Pardo M; Ortiz Sánchez VE; Pérez Valdivieso JM
    Rev Esp Anestesiol Reanim; 2011 Dec; 58(10):624-5. PubMed ID: 22263413
    [No Abstract]   [Full Text] [Related]  

  • 11. Rocuronium-induced neuromuscular block and sugammadex in pediatric patient with duchenne muscular dystrophy: A case Report.
    Kim JE; Chun HR
    Medicine (Baltimore); 2017 Mar; 96(13):e6456. PubMed ID: 28353578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
    Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia.
    Duvaldestin P; Kuizenga K; Saldien V; Claudius C; Servin F; Klein J; Debaene B; Heeringa M
    Anesth Analg; 2010 Jan; 110(1):74-82. PubMed ID: 19933538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study.
    Sorgenfrei IF; Norrild K; Larsen PB; Stensballe J; Ostergaard D; Prins ME; Viby-Mogensen J
    Anesthesiology; 2006 Apr; 104(4):667-74. PubMed ID: 16571960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromuscular block reversal with sugammadex in a morbidly obese patient with myasthenia gravis.
    Jakubiak J; Gaszyński T; Gaszyński W
    Anaesthesiol Intensive Ther; 2012; 44(1):28-30. PubMed ID: 23801510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of reversion of neuromuscular block with sugammadex in patient with myasthenia gravis: case report and brief review of literature.
    Fernandes HDS; Ximenes JLS; Nunes DI; Ashmawi HA; Vieira JE
    BMC Anesthesiol; 2019 Aug; 19(1):160. PubMed ID: 31421671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of sugammadex for the reversal of moderate and deep rocuronium-induced neuromuscular block in patients pretreated with intravenous magnesium: a randomized controlled trial.
    Czarnetzki C; Tassonyi E; Lysakowski C; Elia N; Tramèr MR
    Anesthesiology; 2014 Jul; 121(1):59-67. PubMed ID: 24608361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery of laryngeal nerve function with sugammadex after rocuronium-induced profound neuromuscular block.
    Pavoni V; Gianesello L; Martinelli C; Horton A; Nella A; Gori G; Simonelli M; De Scisciolo G
    J Clin Anesth; 2016 Sep; 33():14-9. PubMed ID: 27555126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Sugammadex in an octagenerian with Myaesthenia Gravis undergoing emergency laporotomy.
    Shah D; Dharmarajah A
    J Clin Anesth; 2017 Feb; 37():109-110. PubMed ID: 28235495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sugammadex given for rocuronium-induced neuromuscular blockade in infants: a retrospectıve study.
    Ozmete O; Bali C; Cok OY; Turk HE; Ozyilkan NB; Civi S; Aribogan A
    J Clin Anesth; 2016 Dec; 35():497-501. PubMed ID: 27871583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.